Eric K Olson appointed CEO and president of SINTX

SINTX Technologies, Inc., Salt Lake City, Utah, USA, has announced that its board of directors has appointed Eric K Olson to succeed B Sonny Bal, MD, as the company’s Chief Executive Officer and president. Olson’s appointment follows the retirement of Dr Bal, who will continue to serve as chairman of the board.

Olson has been a serial founder and entrepreneur in a range of medical device, diagnostic, biologic and biomaterial companies for over thirty years. Most recently Olson was the founder, Chief Executive Officer and board member of Foresite Innovations, LLC, a private healthcare development holding company.

Olson previously served as CEO, president, and a member of the board of directors for the company while it was known as Amedica Corporation. Olson was reputed to have played a key role in the company’s 2014 initial public offering and became listed on the NASDAQ Capital Market. Olson has served in senior executive roles of president, Chief Executive Officer and as a member of the board of directors.

“On behalf of SINTX’s board, I am extremely excited that Eric has agreed to serve as our next CEO and president,” said Dr Bal. “Eric brings many years of experience and leadership qualities that will be crucial in guiding the Company in the coming years.”

“We remain focused on accelerating development and commercialisation of the Company’s technologies and looking for new opportunities that will enhance shareholder value,” stated Olson.

The SINTX Board of Directors also designated Gregg Honigblum as board advisor. Honigblum has over thirty-five years of experience as a financial advisor and is a Managing Director for FNEX Securities. From 2003 to 2013, Honigblum was responsible for raising the company’s private equity funding prior to its IPO in 2014. From, 2006 to 2013, Honigblum was a member of the board of directors of SINTX Technologies.

sintx.com/